Di Bella, Daniela J. http://orcid.org/0000-0001-6141-3704
Habibi, Ehsan http://orcid.org/0000-0002-7208-7999
Stickels, Robert R. http://orcid.org/0000-0003-4326-4084
Scalia, Gabriele http://orcid.org/0000-0003-3305-9220
Brown, Juliana
Yadollahpour, Payman http://orcid.org/0000-0003-1984-5014
Yang, Sung Min http://orcid.org/0000-0003-4318-2011
Abbate, Catherine
Biancalani, Tommaso http://orcid.org/0000-0001-9104-9755
Macosko, Evan Z. http://orcid.org/0000-0002-2794-5165
Chen, Fei
Regev, Aviv http://orcid.org/0000-0003-3293-3158
Arlotta, Paola
Article History
Received: 29 June 2020
Accepted: 24 May 2021
First Online: 23 June 2021
Change Date: 2 August 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-021-03797-5
Competing interests
: P.A. is a scientific advisory board member for System 1 Biosciences and Foresite Labs and is a co-founder of Serqet Therapeutics. A.R. is a co-founder of and an equity holder in Celsius Therapeutics, an equity holder in Immunitas, and until 31 July 2020 was a scientific advisory board member of Thermo Fisher Scientific, Syros Pharmaceuticals, Asimov and Neogene Therapeutics. Since 1 August 2020, A.R. has been an employee of Genentech/Roche. Since 1 February 2021, T.B. has been an employee of Genentech. Since 1 January 2021, G.S. has been an employee of Roche.